The type IIa renal sodium-dependent phosphate (Na/P i ) cotransporter Npt2a is implicated in the control of serum phosphate levels. It has been demonstrated previously that renal Npt2a protein and its mRNA expression are both up-regulated by the thyroid hormone T 3 (3,3 ,5-tri-iodothyronine) in rats. However, it has never been established whether the induction was mediated by a direct effect of thyroid hormones on the Npt2a promoter. To address the role of Npt2a in T 3 -dependent regulation of phosphate homoeostasis and to identify the molecular mechanisms by which thyroid hormones modulate Npt2a gene expression, mice were rendered pharmacologically hypo-and hyper-thyroid. Hypothyroid mice showed low levels of serum phosphate and a marked decrease in renal Npt2a protein abundance. Importantly, we also showed that Npt2a-deficient mice had impaired serum phosphate responsiveness to T 3 compared with wild-type mice. Promoter analysis with a luciferase assay revealed that the transcriptional activity of a reporter gene containing the Npt2a promoter and intron 1 was dependent upon TRs (thyroid hormone receptors) and specifically increased by T 3 in renal cells. Deletion analysis and EMSAs (electrophoretic mobilityshift assays) determined that there were unique TREs (thyroidhormone-responsive elements) within intron 1 of the Npt2a gene. These results suggest that Npt2a plays a critical role as a T 3 -target gene, to control phosphate homoeostasis, and that T 3 transcriptionally activates the Npt2a gene via TRs in a renal cellspecific manner.
INTRODUCTION
Several organs play a crucial role in vertebrate P i (inorganic phosphate) homoeostasis. The daily need for P i is fulfilled by intestinal absorption of P i from the diet. Bones are the major storage compartment for P i and P i is needed in the intracellular spaces for metabolic and structural purposes. The extracellular concentration of P i is controlled via tightly regulated renal excretion [1] . Several types of mammalian renal Na/P i (sodiumdependent phosphate) co-transporters have been isolated and characterized [2, 3] . Renal proximal tubular P i re-absorption is mainly mediated by the renal Na/P i co-transporters Npt2a, Npt2c and Npt1 (type IIa, IIc and type I Na/P i co-transporter respectively) in the BBM (brush border membrane) and Npt2b (type IIb Na/P i co-transporter) expression, which has been reported in many tissues, including the lung and the small intestine [3] [4] [5] .
Hypophosphataemia (a low level of blood phosphate) is seen in several bone diseases, such as vitamin D-dependent rickets type II, X-linked vitamin D-resistant hypophosphataemic rickets and oncogenic osteomalacia [6, 7] . These hypophosphataemias are caused by abnormalities of vitamin D, PTH (parathyroid hormone) and FGF-23 (fibroblast growth factor-23) metabolism [8, 9] . In contrast, hyperphosphataemia occurs in a significant proportion of patients with hyperthyroidism disorders, such as Graves' disease [10] . Indeed, administration of the thyroid hormone T 3 (3,3 ,5-tri-iodothyronine) in rats increases Na/P i transport activity [11] [12] [13] [14] , as well as the protein abundance of Npt2a in BBMVs (BBM vesicles) in the kidney and mRNA levels of renal Npt2a [14, 15] . In addition, stimulatory effects of thyroid hormone on P i transport activity have been observed in primary cultured chick cells and opossum kidney cells and these effect were shown to be dependent on mRNA and protein synthesis [16, 17] . Although these results indicate that T 3 is involved in the induction of renal P i uptake and Npt2a gene expression, there has been no previous direct evidence that Npt2a plays a critical role in the control of plasma P i levels by T 3 or that the promoter activity of the Npt2a gene is induced by T 3 .
Thyroid hormone action is mediated by the TRs (thyroid hormone receptors), members of the nuclear receptor superfamily of ligand-dependent transcription factors [18] . The TRs are encoded by two genes, TRα and TRβ, each of which produces Abbreviations used: AF-2, activation functional 2; BBM, brush border membrane; BBMV, BBM vesicle; β-gal, β-galactosidase; Cre, creatinine; CREB, cAMP-response-element-binding protein; 1,25(OH) 2 D 3 , 1α,25-dihydroxyvitamin D 3 ; DMEM, Dulbecco's modified Eagle's medium; DR-4, direct repeat-4; EMSA, electrophoretic mobility-shift assay; FBS, fetal bovine serum; FGF-23, fibroblast growth factor-23; MDCK, Madin-Darby canine kidney; Na/P i cotransporter, sodium-dependent phosphate co-transporter; NF-κB, nuclear factor κB; Npt1, type Ia Na/P i co-transporter; Npt2a, type IIa Na/P i co-transporter; Npt2a-TRE, Npt2a-TRE sites in intron 1; Npt2a-v1, Npt2a variant 1; Npt2a-v2, Npt2a variant 2; Npt2c, type IIc Na/P i co-transporter; OK-P, opossum kidney-P; PTH, parathyroid hormone; PTU, 6-N-propyl-2-thiouracil; qRT-PCR, quantitative real-time PCR; RXR, retinoid X receptor; T 3 , 3,3 ,5-tri-iodothyronine; TK, thymidine kinase; TR, thyroid hormone receptor; TRE, thyroid-hormone-responsive element; Triac, 3,3 ,5-tri-iodothyroacetic acid. 1 These authors contributed equally to this work. 2 To whom correspondence should be addressed (email yamamoto@nutr.med.tokushima-u.ac.jp).
several isoforms [18] . The TRs bind to specific DNA sequences, TREs (thyroid-hormone-response elements), as monomers, homodimers or heterodimers with the RXR (retinoid X receptor). As RXR enhances the binding affinity of TR for the TRE it has been suggested that TR-RXR heterodimers are the major protein complexes that mediate thyroid hormone responses in vivo [19] . TREs comprise a consensus TR-binding site known as DR-4 (direct repeat-4), which have direct repeats of five nucleotides spaced by four nucleotides. The consensus sequence matches that described by Umezono et al. [19a] and is a sequence of '5 -AGGTGAcaggAGGACA-3 ', which matches the TRE from MHCα (myosin heavy chain α). Our group previously isolated the human and rat Npt2a genes [20, 21] and characterized the human Npt2a promoter [22] . Furthermore, we identified two variant transcripts of the mouse Npt2a gene and demonstrated renal-cell-specific regulation of their alternative promoters by 1,25(OH) 2 D 3 (1, 25-dihydroxyvitamin D 3 , also known as cholecalciferol) [23] . However, it has not been established whether the promoter of the Npt2a gene is responsive to T 3 and whether TREs exist in the Npt2a gene.
In the present study, we have used Npt2a-deficient mice (Npt2a −/− ) to determine whether Npt2a plays a critical role in the T 3 -dependent regulation of P i homoeostasis. We have also shown that T 3 increases the transcriptional activity of the mouse Npt2a gene in a T 3 -dependent and cell-specific manner through TREs in intron 1.
EXPERIMENTAL Animals and experimental design
Five-week-old C57BL/6J mice were purchased from Clea Japan and housed in plastic cages. Male and female Npt2a +/− mice were purchased from The Jackson Laboratory and crossing male and female Npt2a +/− yielded the Npt2a −/− mice, as described previously [24] . Mice were maintained under pathogen-free conditions and handled in accordance with the Guidelines for Animal Experimentation of the Tokushima University School of Medicine. Wild-type mice and Npt2a −/− mice were genotyped by PCR amplification of genomic DNA. PCR genotyping to confirm the Npt2a gene ablation was performed by using a thermal cycler (Shimazu) with a sense primer (5 -TGCCCAGGTTGGC-ACGAAGC-3 ) located in exon 4 of Npt2a and either antisense primer 1 (5 -AGTCCTGTCCCTGCCTGCA-3 ) located in exon 6 of Npt2a or antisense primer 2 (5 -TGCTACTTC-CATTTGTCACGTCC-3 ) located in the introduced neo r gene cassette [24] .
Hypothyroid animals were produced by administration of 0.15 % PTU (6-N-propyl-2-thiouracil; Sigma-Aldrich) in the drinking water for 21 days [25] . Control animals were given tap water during the treatment period. Mice received the water ad libitum and were fed standard mouse chow (Oriental Laboratories). The litters from the PTU group were divided into two or three groups on day 21. The mice in the experimental groups were given T 3 (Sigma-Aldrich) or Triac (3,3 ,5-triiodothyroacetic acid; Wako) at 0.2 mg/100 g of body weight per day by intraperitoneal injection [25] . Mice in the control group were given a similar volume of vehicle (sham-injected controls). T 3 or Triac was dissolved in a small volume of 0.01 M NaOH and pH-neutralized before injection. For biochemical analysis of the serum and kidneys, blood was collected by puncture of the abdominal aorta, and both kidneys were quickly removed under pentobarbital anaesthesia. Serum P i , calcium and Cre (creatinine) levels were measured as described previously [26] . One half of each kidney (transversal section) was used for RNA isolation, and the other half for isolation of BBMVs.
Preparation of BBMVs and immunoblot analysis
BBMVs were prepared from mouse kidney cortex by the calcium precipitation method as described previously [27] . BBMV protein samples were heated at 95
• C for 5 min in sample buffer in the presence of 5 % (v/v) 2-mercaptoethanol and subjected to SDS/PAGE. The separated proteins were transferred electrophoretically on to Hybond TM -P PVDF membranes (GE Healthcare). The membranes were treated with affinity-purified anti-Npt2a antibody (at a 1:4000 dilution) or anti-Npt1 antibody (at a 1:500 dilution) [22] , and then with horseradish peroxidaseconjugated anti-(rabbit IgG) antibody (Jackson ImmunoResearch Laboratories). Signals were detected using the ECL (enhanced chemiluminescence) Plus system (GE Healthcare).
qRT-PCR (quantitative real-time PCR)
First-strand cDNA was synthesized from 1 μg of DNase Itreated total RNA primed with oligo-dT using the MMLV (Moloney-murine-leukaemia virus)-reverse transcriptase kit from Invitrogen. After preparation of the first-strand cDNA, a onetenth volume (1 μl) of the cDNA was used for qRT-PCR. qRT-PCR was performed using the LightCycler system (Roche Diagnostics), as described previously [23] , and the results for Npt2a, Npt2c and Npt1 were normalized to that of β-actin. For PCR amplification, the primer sequences were: for Npt2a (GenBank ® accession number NM_011392), 5 -CTCATTG-TGGGTGCCCAACATGATG-3 and 5 -ACCATGTGTCTCCC-ACGGACTGGAAG-3 ; for Npt2c (GenBank ® accession number NM_080854), 5 -CCGCTGAAGAACGCTGACCAACTGA-3 and 5 -CCACCATGCTGACCACGATAGAGGA-3 ; for Npt1 (GenBank ® accession number NM_009198), 5 -GGGTTCTG-TTCCTTCCGGTATGG-3 and 5 -GAGCCTGAACCACGAC-CATACCA-3 ; and for β-actin (GenBank ® accession number NM_007393), 5 -CATCGTGGGCCGCTCTAGGCACCA-3 and 5 -CGGTTGGCCTTAGGGTTCAGGGGG-3 . The Npt2a variant primer set (for Npt2a-v1 and Npt2a-v2) was described previously [23] ; for amplification of luciferase (GenBank ® accession number NM_075830) the sense primer for either Npt2a-v1 or Npt2a-v2 was used with the antisense primer 5 -GC-CCATACTGTTGAGCAATTCACG-3 .
Cell culture
OK-P (opossum kidney-P) cells [28] were a gift from Dr Judith A. Cole (Department of Biology, University of Memphis, Memphis, TN, U.S.A). MDCK (Madin-Darby canine kidney), COS-7 (non-renal epidermal), HepG2 (hepatic) and HeLa (cervix carcinoma) cells were obtained from the Riken Cell Bank. OK-P, MDCK, COS-7, HepG2 and HeLa cells were all cultured in DMEM (Dulbecco's modified Eagle's medium; Gibco) at 37
• C under an atmosphere containing 5 % CO 2 . The growth medium was supplemented with 10 % (v/v) FBS (fetal bovine serum; Sigma-Aldrich), 100 units/ml penicillin and 0.1 mg/ml of streptomycin. The growth medium for the OK-P cells was additionally supplemented with 25 mM Hepes (pH 7.4) and 1 mM sodium pyruvate.
Plasmid construction
cDNA fragments from rat TRα1, mouse TRβ1 (GenBank ® accession numbers NM_001017960 and NM_009380 respectively) were amplified by RT (reverse transcription)-PCR and the PCR products were subcloned using the pGEM-T easy vector (Promega). The open-reading frames were isolated by digestion with EcoRI or NotI, and inserted into the pcDNA3.1 vector (Invitrogen). Reporter plasmids, containing promoter sequences from the mouse Ntp2a gene, pNp-2.6-Ex2, pNp-2.6-AB, pNp-2.6-A, pNp-1.3-B, pNp-0.6-B and pNp-0.3-B, were as described previously [23] . Reporter plasmids pNp-0.6-Ex2, pNp-0.17 Del.1, pNp-2.6-Ex2 Del.2, pNp-0.17 Del.2 and pNp-0.17 Del.3 were constructed from the pNp-2.6-Ex2 clone using the restriction enzyme sites SmaI, EcoRI, EcoRV and XhoI. The pNp-2.6-Ex2 Del.1 plasmid vector was constructed from the pNp-2.6-Ex2 clone by PCR amplification with specific primers [5 -TGAGGTTCTCTGCCAACAG-3 (from −1435 to −1417 relative to the transcription start site of the variant 2 transcript) and 5 -GTGAGCCCAGGGCCCCTGTGTC-3 (+ 43 to + 64)]. A DNA fragment of the mouse Ntp2a promoter, corresponding to nucleotides + 198 to + 299, was subcloned into the XhoI and KpnI sites of a pGL3-TK vector containing the TK (thymidine kinase) promoter [29] . All reporter plasmids were cloned into the pGL3-basic reporter vector (Promega) and purified with a plasmid purification kit from Qiagen. The orientation and cloning boundaries of all constructs were verified through DNA sequence analysis.
Transfection and luciferase assay
Transfection of the cells was performed using the Lipofectamine TM reagent (Invitrogen) as described previously [30] . Cells were transfected with 0.4 μg of the luciferase reporter plasmid, 0.2 μg of the TRα1 and TRβ1 expression vectors (pcDNA-TRα1 and pcDNA-TRβ1) and 0.2 μg of the RXRα expression vector pSG5-RXRα. The DNA/Lipofectamine TM mixture was removed after 4 h, and cells were grown in DMEM containing 10 % (v/v) FBS and then treated with T 3 or Triac for an additional 24 h. Normalization of luciferase activity for transfection efficiency was determined by co-transfection with 0.2 μg of pCMV-β (Stratagene), a β-gal (β-galactosidase) expression vector. Cells were harvested in cell lysis buffer (Toyo Ink) and the lysates were assayed for luciferase activity, β-gal activity and protein concentration.
Extraction of nuclear protein
Nuclear extracts were prepared according to a mini-extraction protocol with minor modifications [31] . Briefly, cells were cultured on 35-mm dishes to 90 % confluence and transfected with pCMV-FLAG vectors expressing FLAG-tagged TRα and RXRα. After washing, cells were harvested by scraping into ice-cold PBS and collected by centrifugation at 500 g for 5 min. Cells were lysed with buffer A (10 mM Hepes, pH 7.9, containing 10 mM KCl, 0.1 mM EDTA, 0.5 % Nonidet P40, 1 mM dithiothreitol and 0.5 mM PMSF) on ice for 20 min and then centrifuged at 14 000 g for 15 min at 4
• C. The nuclear pellets were washed three times with buffer A and resuspended in buffer C (20 mM Hepes, pH 7.9, 0.5 M KCl, 1 mM EDTA, 1 mM dithiothreitol and 1 mM PMSF) for 30 min at 4
• C on a rotating wheel and then centrifuged at 14 000 g for 15 min at 4
• C.
Coupled transcription/translation assays
Each TRβ1 and RXRα protein was synthesized in vitro under the control of the T7 promoter using a TNT Quick Coupled Transcription/Translation System (Promega) at 30
• C for 90 min in the presence of 20 μM methionine. Generated proteins were used for EMSAs (electrophoretic mobility-shift assays).
EMSAs
EMSAs were performed as described previously [29] . Doublestranded nucleotides containing TRE-A (5 -GCACCTGTCCT-GTCCTGTCCTGCCC-3 and 5 -AGGGCAGGACAGGACAG-GACAGGTG-3 ), TRE-B (5 -CCCTGCCCTGCCCTGCCCTA-CCC-3 and 5 -GGGTAGGGCAGGGCAGGGCAGGG-3 ), DR-4 (5 -TCGAGCTTCAGGTCACAGGAGGTCAGAGAC-3 and 5 -TCGAGTCTCTGACCTCCTGTGACCTGAAGC-3 ) and the NF-κB (nuclear factor κB)-binding site (5 -AGTTGAGGGGA-CTTTCCCAGGC-3 and 5 -GCCTGGGAAAGTCCCCTCAA-CT-3 ) were synthesized by annealing two oligonucleotides. A DNA fragment containing the TREs from Npt2a was PCR-amplified using Npt2a-gene-specific primers [5 -TGCTC-TTCCTTCTCTCGAGAGCACCTG-3 (+ 180 to + 206) and 5 -AGGTACCACTATGCCTAGAGTG-3 (+ 279 to + 300)]. Each purified DNA fragment was labelled with [γ -33 P]ATP (110 TBq/mmol) using T4 polynucleotide kinase (Takara). Prepared nuclear protein and the in vitro-translated protein (10 μg and 2 μl respectively) were incubated with the radiolabelled probe in binding buffer [10 mM Tris/HCl, pH 7.5, containing 1 mM MgCl 2 , 1 mM dithiothreitol, 1 mM EDTA, 10 % (v/v) glycerol, 2 mg/ml BSA, 1 μg of poly(dI-dC) and 750 ng of denatured salmon sperm DNA] in a final volume of 20 μl for 30 min at room temperature (approx. 24
• C). The reaction mixture was then subjected to PAGE (5 % gel), with 0.25× TBE (Tris/borate/EDTA; 1× TBE is 90 mM Tris/HCl, pH 8.3, 64.6 mM boric acid and 2.5 mM EDTA) as the electrode buffer, at a constant current of 20 mA for 1 h. The gel was dried and analysed with the Fujix Bio-imaging analyser BAS-1500 (Fujifilm).
Statistical Analysis
Results are presented as the means + − S.E.M. Statistical significance is defined as P < 0.05 between groups and was determined by ANOVA, followed by post-hoc testing using Fisher's PLSD (protected least significant difference) procedure for multiple comparisons.
RESULTS

In vivo effects of PTU treatment on plasma P i levels and renal expression of the Npt2a gene
It has been reported that hypothyroid rats exhibit a significant decrease in serum P i levels and BBM Npt2a protein and mRNA expression [15] . To elucidate the in vivo effects of thyroid hormones on plasma P i levels and renal Npt2a expression in mice, hypothyroid and hyperthyroid mouse models were developed. Plasma levels of total T 3 and T 4 (thyroxine) were significantly (P < 0.001 by Student's t test) decreased in PTU mice (39 + − 4.8 ng/dl and 0.67 + − 0.29 μg/dl) compared with control mice (61 + − 3.7 ng/dl and 3.68 + − 1.15 μg/dl). As reported previously for rats [11] [12] [13] [14] , the plasma P i level of PTU-treated mice was also markedly decreased compared with control mice or mice treated with T 3 and PTU ( Figure 1A ). Western blotting of BBM proteins from the kidney showed that the abundance of renal Npt2a was significantly decreased in PTU-treated mice compared with control and PTU-and T 3 -treated mice, whereas the relative abundance of Npt1 protein did not change ( Figure 1B) . We then performed qRT-PCR analysis to measure the renal Npt2a, Npt2c, and Npt1 mRNA levels in PTU-treated and control mice. As shown in Figure 1 (C), PTU-treated mice exhibited a significant decrease in renal mRNA levels of Npt2a, but not of Npt2c and Npt1 mRNA.
Effects of Npt2a gene ablation on T 3 -mediated regulation of plasma and urine P i levels
To determine the role of Npt2a in the T 3 -dependent regulation of P i homoeostasis in the kidney, we tested the effects of T 3 in wildtype and Npt2a −/− mice. As expected, in wild-type mice the levels of renal Npt2a protein and plasma P i were markedly increased by T 3 , and the urine P i /Cre ratio was significantly decreased by T 3 (Figures 2A-2C) . Importantly, these effects of T 3 on plasma and urine P i levels were abolished in Npt2a −/− mice ( Figures 2B  and 2C) . It is well known that T 3 has an inhibitory effect on plasma cholesterol levels; Figure 2 (D) shows that T 3 was able to decrease plasma cholesterol levels in both wild-type and Npt2a
Transcriptional regulation of the Npt2a gene promoter by T 3 In our previous study [23] , we identified two variant transcripts of the mouse Npt2a gene, Npt2a-v1 and Npt2a-v2, characterized by the presence of alternative first exons (either exon 1A or exon 1B), the expression of which was driven by two promoters (promoter 1 and promoter 2 respectively) contained within a 2.6-kb region 5´of exon 1B ( Figure 3A Figure S1 available at http://www.BiochemJ.org/bj/427/bj4270161add.htm). To understand the molecular mechanisms behind the regulation of Npt2a gene expression by T 3 , a luciferase assay was performed to analyse the responsiveness of the Npt2a gene promoter to T 3 . We utilized the pNp-2.6-Ex2 reporter construct, which contained promoter 1, exon 1A, promoter 2, exon 1B, intron 1 and exon 2 fragments of the mouse Npt2a gene, in OK-P cells ( Figure 3A) . As shown in Figure 3 (B), T 3 stimulated the transcriptional activity of the pNp-2.6-Ex2 reporter construct in OK-P cells and this stimulation was TR-and RXR-dependent. Luciferase activity of the pNp-2.6-Ex2 reporter construct was dose-dependently increased by T 3 in OK-P cells overexpressing TRα1 and RXRα; however, expression of TRα-AF2, lacking the AF-2 (activation functional 2) domain, markedly reduced the T 3 -dependent activation of the Npt2a gene promoter compared with wild-type TRα1 ( Figure 3C ). Triac is a T 3 analogue with a higher binding affinity for TRβ1 and an affinity for TRβ1 that is twice as high as its affinity for TRα [32] . However, the ability of Triac to increase the activity of the pNp-2.6-Ex2 reporter in OK-P cells overexpressing TRα and RXRα or TRβ1 and RXRα was similar to T 3 (results not shown). In addition, we tested the ability of T 3 to stimulate the Npt2a gene promoter in renal and non-renal cells overexpressing TRα1 and RXRα. Interestingly, activation of the Npt2a gene promoter by T 3 was observed in OK-P cells and MDCK cells, which are derived from renal proximal tubular cells, but not in other cell lines, such as COS-7 (kidney), HeLa (cervix) or HepG2 (liver) cells ( Figure 3D ).
Identification of a thyroid-hormone-responsive region in the Npt2a gene
In order to clarify which areas of the promoter were responsible for the T 3 -mediated activation of the Npt2a gene, several reporter constructs with various deletions of the 5 -region of the Npt2a gene were tested in TRα1 and RXR co-expressing OK-P cells, with or without T 3 . The reporter constructs pNp-2.6-Ex2, pNp-0.6-Ex2 and pNp-2.6-Ex2 Del.1, which contain most of the intron 1 sequence, showed significantly increased luciferase activity in response to T 3 , whereas the constructs lacking intron 1 and exon 2 (pNp-2.6-A, pNp-0.6-B) or pNp-2.6-Ex2 Del.2 (which had a deletion of part of promoter 2 and intron 1; residues + 42 to + 302) had virtually no luciferase activity ( Figure 4A ). These results indicate that T 3 is capable of activating both promoter 1 and promoter 2 of the Npt2a gene through the intron 1 region, especially the region between + 42 and + 302, in OK-P cells. Figure S2A (available at http://www.BiochemJ.org/bj/427/bj4270161add.htm) both renal Npt2a-v1 and Npt2a-v2 mRNA levels decreased in the PTUtreated mice group compared with the control group. Moreover, the mRNA expression of both Npt2a-luciferase variants, produced from the pNp-2.6-Ex2 reporter plasmid vector in OK-P cells when co-expressed with TRα and RXRα, were stimulated by T 3 (Supplementary Figure S2B) . Next, reporter constructs with various deletions in intron 1 of the mouse Npt2a gene were examined. As shown in Figure 4 (B), in contrast with pNp-0.17-Ex2 and pNp-0.17 Del.1, both reporter plasmids containing deletions of the region from + 198 to + 299 in intron 1 (pNp-0.17 Del.2 and pNp-0.17 Del.3) did not respond to T 3 . In addition, pTK-NptTRE, a chimaeric plasmid containing the fragment from + 198 to + 299 in intron 1 of the mouse Npt2a gene linked to the TK reporter, did respond to T 3 ( Figure 4B ). These results suggest that the region between + 198 and + 299 in intron 1 is important for the T 3 -dependent activation of the Npt2a gene promoter in OK-P cells.
Indeed, as shown in Supplementary
Binding of a TR-RXR heterodimer to the TRE region
On the basis of our deletion analysis (Figure 4) , we hypothesized that TRs could bind to the region between + 198 and + 299 in the mouse Npt2a gene promoter, so we refer to this region as the Npt2a-TRE. Surprisingly, we found that the Npt2a-TRE is comprised of seven repeats of the sequence AGGGCA, AGGACA or AGGGTA with the half-sites arrayed as direct repeats spaced by four nucleotides (i.e. a DR-4 region; Figure 5A ). This DNA fragment was used in EMSAs to evaluate whether TR and RXR bind to it. As shown in Figure 5 (B), a radiolabelled Npt2a-TRE DNA fragment probe detected two bands in protein extracts prepared from OK-P cells overexpressing FLAG-tagged TRα1 and FLAG-tagged RXRα. These complexes were susceptible to competition with unlabelled Np2a-TRE ( Figure 5B) , and both the consensus sequence of DR-4 and a fragment of part of the Npt2a-TRE, TRE-B ( Figure 5A ), corresponding to nucleotides + 231 to + 254, which includes an AGGGCA half-site. However, the TRE-A ( Figure 5A ) sequence corresponding to + 202 to + 224, also including an AGGACA half-site, only showed weak competition for the complexes. The NF-κB oligonucleotide, used as a non-specific competitor, showed no inhibition. Similar results were also obtained in another competition experiment using a radiolabelled consensus DR-4 probe, although intriguingly the DR-4 probe was only detected as a single band (Supplementary Figure S3 available at http://www.BiochemJ.org/bj/427/bj4270161add.htm) Figure 5 (C) shows that the protein complexed with the Npt2a-TRE DNA probe was supershifted when the anti-FLAG antibody was added. When oligonucleotides TRE-A or TRE-B were used as probes, two bands were detected and the complex was also supershifted with the anti-FLAG antibody; however, the ability to bind to TRα-RXRα was stronger for TRE-B than TRE-A ( Figure 5D ). Two complexes where also seen when using the TRE-B probe with nuclear extracts from COS-7 cells overexpressing TRα1 and RXRα, but a single band was detected when the DR-4 probe and OK-P cells nuclear extracts were used ( Figure 5E ). In addition, we performed an EMSA using in-vitrosynthesized TRβ1 and RXRα proteins. 
DISCUSSION
In previous in vivo studies, the renal BBM transport activity of P i and the expression of the Npt2a gene in the kidney were shown to be induced by thyroid hormones [15] . In in vitro experiments in primary cultured renal cells and the OK-P cell line, T 3 was shown to stimulate P i transport and opossum Npt2a mRNA expression [17] . Analysis using administration of actinomycin D, which is a nuclear RNA synthesis inhibitor, and nuclear run-on experiments using nuclei isolated from kidney cortexes in hypo-and hyperthyroid rats suggested that these effects of T 3 on renal P i uptake and Npt2a gene expression were mediated by transcriptional control [15, 33] . However, it has never been established whether the induction was mediated by a direct effect of thyroid hormone on the Npt2a promoter. In the present study, we have determined that the Npt2a gene is essential for the control of plasma P i levels by T 3 and that the transcriptional activity of the mouse Npt2a gene is up-regulated by T 3 and that this activity is dependent on TRs and is renal cell-specific. The increase of plasma P i levels in mice stimulated by T 3 is consistent with previous studies in rats [15] .
Western blot analysis revealed that T 3 up-regulated the abundance of Npt2a protein in kidney BBMs, but not of the abundance of Npt1. In addition, qRT-PCR analysis revealed that the mRNA levels of renal Npt2a were decreased in PTU-treated mice, but that mRNA levels of other Na/P i co-transporters, such as Npt2c did not change ( Figures 1C and 1D) . Importantly, T 3 injections in Npt2a −/− mice, which are unable to increase their plasma P i levels, also failed to decrease urinary P i excretion (Figures 2B and 2C ). These observations suggest that Npt2a plays a critical role in the control of plasma P i levels by T 3 . It has been reported that dietary P i , FGF-23, PTH and 1,25(OH) 2 D 3 act as P i -regulating factors, directly or indirectly regulating the renal expression of both Npt2a and Npt2c [34] [35] [36] . In humans, Graves' disease patients present with high levels of P i , calcium and FGF-23, but low levels of PTH and 1,25(OH) 2 D 3 in serum [10] . However, it has been reported that T 3 and PTU did not affect the plasma levels of PTH in animal models [14] . Indeed, we observed that T 3 did not change the plasma levels of calcium, PTH and FGF-23 in mice (results not shown).
Although it is possible that T 3 could be a specific Npt2a-regulating factor, which acts to control P i homoeostasis in the kidney, further Transcriptional activity of deletion constructs of the Npt2a gene promoter in OK-P cells. Deletion constructs were generated by PCR amplification or restriction enzyme digestion as described in the Experimental section and as illustrated on the left-hand panels in (A) and (B). Exons (1A, 1B and 2) and the TRE are shown as boxes. The indicated reporter constructs were co-transfected with pcDNA-TRα, pSG5-RXRα and pCMV-β in OK-P cells. Cells were incubated in the presence (black columns) or absence (white columns) of 100 nM T 3 for 24 h. Cells were then harvested and assayed for luciferase and β-gal activity. Each data point represents the means + − S.E.M for four samples, normalized to the β-gal activity. Similar results were obtained from three independent experiments. **P < 0.01 compared with the vehicle control. study on the direct and indirect regulation of P i -and calciumregulating factors, such as PTH, FGF-23 and 1,25(OH) 2 D 3 , by T 3 are required to understand the network of control systems underlying P i and calcium homoeostasis in the whole body.
To better understand the regulation of mouse Npt2a gene expression by T 3 , functional promoter analysis was performed using a reporter plasmid, including the 5 -flanking region and intron 1, in OK-P cells. Figure 3 shows that the activity of the Npt2a gene promoter was increased by T 3 in OK-P cells overexpressing both TR and RXR and that the T 3 -dependent activation of its promoter was abolished when the AF-2 in TRα was deleted. A T 3 analogue, Triac, also increased the plasma P i levels in mice and Npt2a gene promoter activity in OK-P cells to the same extent as T 3 (results not shown). Furthermore, T 3 increased the activity of the Npt2a gene promoter in a renal cell-specific manner.
Deletion analysis indicated that the Npt2a-TRE region, from + 198 to + 299 bp in intron 1, was important for T 3 -dependent activation of the gene in OK-P cells. This Npt2a-TRE comprised seven repeats of the sequence AGGGCA, AGGACA or AGGGTA with these half-sites arrayed as direct repeats spaced by four nucleotides (i.e. a DR-4). EMSA revealed that Npt2a-TRE, especially the TRE-B sequence (5 -ggtAGGGCAgggcAGGGCAgggc-3 ), which included an AGGGCA half-site, responds to TR and RXR. Interestingly, Npt2a-TRE and TRE-B, but not the consensus DR-4 sequence, showed multiple complexes in either OK-P or COS-7 cells co-expressing TRα and RXRα. This could suggest that the third half-site in TRE-B, 'AgggcA', might affect protein-DNA complex formation. These results suggest that the renal cellspecific factors, required to activate the Npt2a gene promoter, associate with other cis-elements and not Npt2a-TRE. However, the presence of further binding proteins in addition to TR and RXR might explain the observation of different protein-DNA complexes is Figures 5(D) and 5(F). Hilfiker et al. [37] have demonstrated that a kidney-specific 31-kDa nuclear protein binds to the CAAT-box in the Npt2a gene proximal promoter region using Southwestern blotting techniques. The identification of master regulatory genes which to control Npt2a gene expression and/or P i homoeostasis in renal proximal tubular cells is clearly needed to uncover the molecular basis of cell-specific Npt2a gene regulation.
TREs are generally found in the proximal region of promoters, as for the malic enzyme [38] , myelin basic protein [39] and APOA5 (apolipoprotein A5) [40] . However, there are some TREs that are located in a far upstream 5 region or downstream intron 32 P-labelled Npt2a-TRE as a probe. EMSAs were performed with nuclear extracts (N.E.) from OK-P cells overexpressing FLAG-TRα and FLAG-RXRα, with the addition of unlabelled competitor oligonucleotides as indicated. Self, Npt2a-TRE; DR4, consensus DR4; A, TRE-A; B, TRE-B; NS, non-specific competitor (the NF-κB-binding sequence). A 50-fold molar excess of each competitor was used. (C) EMSAs using 32 P-labelled Npt2a-TRE as a probe. EMSAs were performed with nuclear extracts (N.E.) from OK-P cells overexpressing FLAG-TRα and FLAG-RXRα and antibodies as indicated. (D and E) EMSAs using 32 P-labelled TRE-A, TRE-B or DR-4 as probes. EMSAs were performed and using nuclear extracts from (D) OK-P or (E) OK-P (OK) or COS-7 (COS7) cells overexpressing FLAG-TRα and FLAG-RXRα and antibodies as indicated. (F) EMSAs using 32 P-labelled TRE-B as a probe and using nuclear extracts from OK-P cells. FLAG-TRα, FLAG-RXRα and antibodies were present as indicated. αTR, TR-specific antibody; αcfos; c-Fos-specific antibody; αflag, anti-FLAG antibody. The location of the DNA-protein complex band and the super-shifted band are indicated by arrows.
region. For example, the TREs in the rat growth hormone and the matrix metalloproteinase stromelysin-3 genes are located in the third intron downstream of the respective transcription start sites [41, 42] . Endogenous TREs are often clustered and arranged with multiple repeats of half-sites, which function synergistically or co-operatively. Similarly, the Npt2a-TRE located in the first intron region includes multiple half-sites and is necessary for full responsiveness to T 3 -mediated activation in the presence of TR and RXR (Figures 3-5 ). There are also some putative regulatory elements including GATA-and CREB (cAMP-response-elementbinding protein)-binding consensus sequences and E-boxes in first intron region of the Npt2a gene (Supplementary Figure S1) . We have reported previously that the mouse transcription factor Tcfe3 (transcription factor E3) binds an E-box element in the human Npt2a gene promoter [43] . Further study is therefore necessary to understand the role of the P i -regulating network on the transcriptional regulation of the renal Npt2a gene.
In conclusion, the Npt2a gene plays a critical role, as a target gene of thyroid hormones, in renal P i homoeostasis and its induction by T 3 is transcriptionally regulated by TR-RXR through a T 3 response region, including multiple DR-4 motifs, located in intron 1 of the Npt2a gene. EMSA using a radiolabelled consensus DR-4 probe was performed with nuclear extracts from OK-P cells overexpressing FLAG-TRα and FLAG-RXRα with the addition of unlabelled competitor oligonucleotides, including consensus DR-4 (Self) and TRE-A (A) and TRE-B (B) as non-specific competitors. A 50-fold molar excess of each competitor was used. The location of the DNA-protein complex band is indicated by the arrow. N.E., OK-P nuclear extract; −, no addition.
